Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Cytek Biosciences (CTKB) Shares Issued (2020 - 2025)

Cytek Biosciences' Shares Issued history spans 6 years, with the latest figure at $446000.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 36.01% year-over-year to $446000.0; the TTM value through Dec 2025 reached $1.1 million, down 32.57%, while the annual FY2025 figure was $1.1 million, 32.57% down from the prior year.
  • Shares Issued reached $446000.0 in Q4 2025 per CTKB's latest filing, down from $664000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $889000.0 in Q4 2023 to a low of $17000.0 in Q4 2021.
  • Average Shares Issued over 5 years is $385529.4, with a median of $364000.0 recorded in 2022.
  • Peak YoY movement for Shares Issued: soared 888.24% in 2022, then plummeted 92.29% in 2025.
  • A 5-year view of Shares Issued shows it stood at $17000.0 in 2021, then skyrocketed by 888.24% to $168000.0 in 2022, then skyrocketed by 429.17% to $889000.0 in 2023, then fell by 21.6% to $697000.0 in 2024, then tumbled by 36.01% to $446000.0 in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Shares Issued are $446000.0 (Q4 2025), $664000.0 (Q2 2025), and $39000.0 (Q1 2025).